Treatment with pyrotinib-based therapy in lapatinib-resistant HER2-positive metastatic breast cancer: a multicenter real-world study.
Ther Adv Med Oncol
; 14: 17588359221085232, 2022.
Article
de En
| MEDLINE
| ID: mdl-35356262
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Type d'étude:
Clinical_trials
Langue:
En
Journal:
Ther Adv Med Oncol
Année:
2022
Type de document:
Article
Pays d'affiliation:
Chine
Pays de publication:
Royaume-Uni